Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 40

1.

Multiple Circulating Cytokines Are Coelevated in Chronic Obstructive Pulmonary Disease.

Selvarajah S, Todd I, Tighe PJ, John M, Bolton CE, Harrison T, Fairclough LC.

Mediators Inflamm. 2016;2016:3604842. doi: 10.1155/2016/3604842. Epub 2016 Jul 25.

2.

Peripheral Tc17 and Tc17/Interferon-γ Cells are Increased and Associated with Lung Function in Patients with Chronic Obstructive Pulmonary Disease.

Xu WH, Hu XL, Liu XF, Bai P, Sun YC.

Chin Med J (Engl). 2016 Apr 20;129(8):909-16. doi: 10.4103/0366-6999.179798.

3.

Usefulness of neutrophil to lymphocyte ratio in patients with chronic obstructive pulmonary disease: a prospective observational study.

Lee SJ, Lee HR, Lee TW, Ju S, Lim S, Go SI, You JW, Cho YJ, Lee GW, Jeong YY, Kim HC, Lee JD.

Korean J Intern Med. 2016 Sep;31(5):891-8. doi: 10.3904/kjim.2015.084. Epub 2016 Mar 25.

4.

Plasma Chemokine signature correlates with lung goblet cell hyperplasia in smokers with and without chronic obstructive pulmonary disease.

Kim V, Cornwell WD, Oros M, Durra H, Criner GJ, Rogers TJ.

BMC Pulm Med. 2015 Sep 30;15:111. doi: 10.1186/s12890-015-0103-2.

6.

Therapy with plasma purified alpha1-antitrypsin (Prolastin®) induces time-dependent changes in plasma levels of MMP-9 and MPO.

Koepke J, Dresel M, Schmid S, Greulich T, Beutel B, Schmeck B, Vogelmeier CF, Janciauskiene S, Koczulla AR.

PLoS One. 2015 Jan 30;10(1):e0117497. doi: 10.1371/journal.pone.0117497. eCollection 2015.

7.
8.
9.

A systems biology approach reveals a link between systemic cytokines and skeletal muscle energy metabolism in a rodent smoking model and human COPD.

Davidsen PK, Herbert JM, Antczak P, Clarke K, Ferrer E, Peinado VI, Gonzalez C, Roca J, Egginton S, Barberá JA, Falciani F.

Genome Med. 2014 Aug 9;6(8):59. doi: 10.1186/s13073-014-0059-5. eCollection 2014.

10.

Serum cytokine profiling and enrichment analysis reveal the involvement of immunological and inflammatory pathways in stable patients with chronic obstructive pulmonary disease.

Bade G, Khan MA, Srivastava AK, Khare P, Solaiappan KK, Guleria R, Palaniyar N, Talwar A.

Int J Chron Obstruct Pulmon Dis. 2014 Aug 5;9:759-73. doi: 10.2147/COPD.S61347. eCollection 2014.

11.

FEV1 inversely correlates with metalloproteinases 1, 7, 9 and CRP in COPD by biomass smoke exposure.

Montaño M, Sansores RH, Becerril C, Cisneros J, González-Avila G, Sommer B, Ochoa L, Herrera I, Ramírez-Venegas A, Ramos C.

Respir Res. 2014 Jun 30;15:74. doi: 10.1186/1465-9921-15-74.

12.

Comparison of arterial and venous blood biomarker levels in chronic obstructive pulmonary disease.

Kelly E, Owen CA, Abraham A, Knowlton DL, Celli BR, Pinto-Plata V.

F1000Res. 2013 Apr 19;2:114. doi: 10.12688/f1000research.2-114.v1. eCollection 2013.

13.

Echocardiography, spirometry, and systemic acute-phase inflammatory proteins in smokers with COPD or CHF: an observational study.

Beghé B, Verduri A, Bottazzi B, Stendardo M, Fucili A, Balduzzi S, Leuzzi C, Papi A, Mantovani A, Fabbri LM, Ceconi C, Boschetto P.

PLoS One. 2013 Nov 11;8(11):e80166. doi: 10.1371/journal.pone.0080166. eCollection 2013.

14.

Analysis of the plasma proteome in COPD: Novel low abundance proteins reflect the severity of lung remodeling.

Merali S, Barrero CA, Bowler RP, Chen DE, Criner G, Braverman A, Litwin S, Yeung A, Kelsen SG.

COPD. 2014 Apr;11(2):177-89. doi: 10.3109/15412555.2013.831063. Epub 2013 Oct 10.

15.

Sputum inflammatory cell-based classification of patients with acute exacerbation of chronic obstructive pulmonary disease.

Gao P, Zhang J, He X, Hao Y, Wang K, Gibson PG.

PLoS One. 2013 May 31;8(5):e57678. doi: 10.1371/journal.pone.0057678. Print 2013.

16.

The relation of serum myeloperoxidase to disease progression and mortality in patients with chronic obstructive pulmonary disease (COPD).

Park HY, Man SF, Tashkin D, Wise RA, Connett JE, Anthonisen NA, Sin DD.

PLoS One. 2013 Apr 18;8(4):e61315. doi: 10.1371/journal.pone.0061315. Print 2013.

17.

Smokers with CT detected emphysema and no airway obstruction have decreased plasma levels of EGF, IL-15, IL-8 and IL-1ra.

de-Torres JP, Blanco D, Alcaide AB, Seijo LM, Bastarrika G, Pajares MJ, Muñoz-Barrutia A, Ortiz-de-Solorzano C, Pio R, Campo A, Montes U, Segura V, Pueyo J, Montuenga LM, Zulueta JJ.

PLoS One. 2013;8(4):e60260. doi: 10.1371/journal.pone.0060260. Epub 2013 Apr 5.

18.

Inflammatory markers in chronic obstructive pulmonary disease patients with different α1 antitrypsin genotypes.

Serapinas D, Sitkauskiene B, Sakalauskas R.

Arch Med Sci. 2012 Dec 20;8(6):1053-8. doi: 10.5114/aoms.2012.32414. Epub 2012 Dec 19.

19.

Stage-dependent association of BDNF and TGF-β1 with lung function in stable COPD.

Stoll P, Wuertemberger U, Bratke K, Zingler C, Virchow JC, Lommatzsch M.

Respir Res. 2012 Dec 17;13:116. doi: 10.1186/1465-9921-13-116.

20.

The expanding role of biomarkers in the assessment of smoking-related parenchymal lung diseases.

Doyle TJ, Pinto-Plata V, Morse D, Celli BR, Rosas IO.

Chest. 2012 Oct;142(4):1027-34. doi: 10.1378/chest.12-1540. Review.

Items per page

Supplemental Content

Write to the Help Desk